ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 49 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $5,000 | -44.4% | 13,107 | 0.0% | 0.00% | – |
| Q4 2019 | $9,000 | -30.8% | 13,107 | -29.6% | 0.00% | – |
| Q3 2019 | $13,000 | -45.8% | 18,607 | 0.0% | 0.00% | – |
| Q2 2019 | $24,000 | -44.2% | 18,607 | -8.4% | 0.00% | – |
| Q1 2019 | $43,000 | +34.4% | 20,317 | +41.9% | 0.00% | – |
| Q4 2018 | $32,000 | -54.3% | 14,317 | -28.9% | 0.00% | – |
| Q3 2018 | $70,000 | – | 20,142 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| A.R.T. Advisors, LLC | 20,419 | $16,000 | 0.09% |
| Maven Securities LTD | 1,000,000 | $795,000 | 0.07% |
| Verdence Capital Advisors LLC | 88,382 | $69,000 | 0.02% |
| Hayden Royal, LLC | 26,000 | $20,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 55,752 | $44,000 | 0.01% |
| Qube Research & Technologies Ltd | 519,063 | $407,000 | 0.01% |
| Virtu Financial LLC | 39,683 | $31,000 | 0.01% |
| Global Strategic Investment Solutions, LLC | 23,000 | $18,000 | 0.01% |
| Jacobi Capital Management LLC | 25,000 | $20,000 | 0.00% |
| RVW Wealth, LLC | 19,000 | $15,000 | 0.00% |